Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction
Almudena Mendez-Perez, Andres M Acosta-Moreno, Carlos Wert-Carvajal…·Esteban Veiga
This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.